FPANS

(redirected from Fluticasone Propionate Aqueous Nasal Spray)
AcronymDefinition
FPANSFluticasone Propionate Aqueous Nasal Spray
FPANSForest Products Association of Nova Scotia
References in periodicals archive ?
Rhinitis, allergic, seasonal; Ioratadine; antihistamine; fluticasone propionate aqueous nasal spray [non-MeSH].
One currently available intranasal corticosteroid preparation, fluticasone propionate aqueous nasal spray (FP ANS) (Flonase Nasal Spray, 0.05% w/w, Glaxo Wellcome Inc, NC), was developed to provide a high ratio of local anti-inflammatory to systemic activity.[4-7] In clinical trials of 2 to 4 weeks' duration comparing FP ANS with oral antihistamines, FP ANS demonstrated significantly greater effectiveness than loratadine,[8-11] terfenadine,[12-14] astemizole,[15] and cetirizine[16] in relieving nasal symptoms of rhinitis.
(%) 5 (3) Adverse event 0 (0) Failed to return 1 (<1) Lack of efficacy 2 (1) Other 2 (1) (*) FP ANS = fluticasone propionate aqueous nasal spray 200 pg daily; Ioratadine dosage is 10 mg once daily.
The efficacy of fluticasone propionate aqueous nasal spray for allergic rhinitis and its relationship to topical effects.
A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen.
Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.
Once- versus twice-daily fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis.
A dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis.